News & Articles

Tell us which new products have had the biggest impact on your lab work for a chance to win one of four $100 Amazon.com Gift Cards

ChemPartner's new visual language embodies decades of scientific rigor, adaptive and scalable partnership, and a commitment to visionary life science companies to help them efficiently and rapidly bring life-changing drugs to market

Availability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region

Non-exclusive OEM license grants worldwide rights for Optimer binder in molecular biology applications

Phase 1 trial in aggressive brain cancer (glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platform

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media

Novel treatment offers non-immunosuppressive approach for localized acid neutralization and calcium delivery

Biopharma needs informatics platforms that are unified, flexible, and intelligent – ready not just for today’s science, but for what is coming next

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence

Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments

Explore the future of membrane protein therapeutics with innovative antibody platforms

Collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain

Platform enables direct measure of more than 10,000 proteins in diverse FFPE tissue and tumor samples, integrated multi-omic molecular mapping of tumors

DynamiQ™ integrates diverse breadth of multi-omic measures with paired real-world data from serial samples to enable deep analysis of patient journeys, disease drivers, and drug response

Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market

An interdisciplinary effort to revolutionize imaging of early mammalian development through next-generation intravital microscopy